Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in carbapenem-non-susceptible gram-negative bacilli. [PDF]
Microbiol SpectrKim TY +7 more
europepmc +1 more source
Molecular characterization of Carbapenem-resistant Gram-negative bacilli associated with nosocomial infections in Hail, Saudi Arabia. [PDF]
Ann Saudi MedAlkaik FA +3 more
europepmc +1 more source
Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps. [PDF]
Lancet Reg Health West PacYeoh DK +17 more
europepmc +1 more source
Prescribing Patterns and Clinical Outcomes of Ceftolozane/Tazobactam by Renal Function and Body Mass Index: A SPECTRA Real-World Multi-Country Analysis. [PDF]
Antibiotics (Basel)Yucel E +7 more
europepmc +1 more source
Impact of an infectious disease specialist-led antimicrobial stewardship program and consultations during multiple antimicrobial shortages: A bayesian structural time-series analysis. [PDF]
PLoS OneItoh N +5 more
europepmc +1 more source
Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023). [PDF]
Antibiotics (Basel)Sader HS +4 more
europepmc +1 more source
First nationwide survey on <i>Pseudomonas aeruginosa</i> in Bolivia: susceptibility profiles, resistome, and genomic epidemiology. [PDF]
Antimicrob Agents ChemotherAlvarado-Orosco N +20 more
europepmc +1 more source
The UK Antimicrobial Registry (UKAR): an overview of the first 20 months of recruitment. [PDF]
JAC Antimicrob ResistSneddon J +11 more
europepmc +1 more source